100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Endocrine pharmacology lecture notes summary $7.23   Add to cart

Summary

Endocrine pharmacology lecture notes summary

 0 view  0 purchase
  • Course
  • Institution

Summary of all lecture notes for exam revision. With these notes, I achieved a 1st last year. ONLY 1/4 OF THE WHOLE DRUGS AND DISEASE MODULE. ALSO PURCHASE THE OTHER 3 LECTURE NOTES FOR COMPREHENSIVE NOTES OF THE DRUGS AND DISEASE MODULE.

Preview 3 out of 30  pages

  • April 15, 2024
  • 30
  • 2022/2023
  • Summary
  • Unknown
avatar-seller
Endocrine pharmacology



(Trying to provide drugs that fit in with natural rhythms of body cycles – use agonists – replace failing
signals for example – exploitation of negative feedback processes)



Diabetes

• Diabetes insipidus – defective antidiuretic hormone signaling, causing the production of large
volumes of very dilute urine and a need to greatly increase fluid intake to compensate

• Diabetes mellitus - a group of metabolic diseases characterized by hyperglycaemia resulting
from defects in insulin secretion, insulin action or both.

(“mellitus” comes from Latin (honey-flavoured) - first used in 1675 by Charles Willis -
Increased volumes of sweet urine – tendency to attract insects)



Type 1 diabetes mellitus (T1DM)

 ~8% of cases
 Associated with autoimmune damage to the pancreas and the loss of insulin-
producing  cells, so reduced blood [insulin]
 Body's immune system attacks the pancreatic beta cells that produce insulin
 “Insulin-dependent diabetes mellitus”

Type 2 diabetes mellitus (T2DM)

 ~90% of cases
 Associated with insulin resistance, with elevated blood [insulin] but reduced
tissue responses
 Genetic predisposition (higher in certain ethnic groups) with interaction with
environmental factors (lifestyle, in utero conditions)
 “Non-insulin-dependent diabetes mellitus”

A new patient is diagnosed with T2DM every 2 minutes

NHS spending on diabetes >£10 billion, ~10% of the entire budget



Risks and consequences of diabetes:

Not because of hyperglycaemia but due to its metabolic consequences…

- Stroke
- 2- to 4-fold increase in cardiovascular mortality and stroke
- Cardiovascular Disease
- 80% of diabetic patients die from CV events
- Diabetic Neuropathy

, - Leading cause of non-traumatic lower extremity amputations. “Diabetic foot” related to
sensory neuropathy (loss of sensation) so injuries not detected and poor wound healing due
to damaged vasculature
- Diabetic Nephropathy
- Leading cause of end-stage renal disease due to loss of protein (albumin) in urine linked to
peripheral oedema; eventual loss of filtration function of kidney
- Diabetic Retinopathy
- Leading cause of blindness in working-age adults linked to damage to small blood vessels in
the retina
- Diabetes risk factor for death/long hospitalisation for Covid-19 due to poor glycaemic control



- Many of the detrimental effects of diabetes are linked to vascular pathology, particularly
atherosclerosis formation leading to atherosclerotic diseases, particularly coronary heart
disease and stroke
- Chemical modification of proteins by glucose / increased oxidative stress leads to cellular
dysfunction
- Diabetes linked to elevated LDL cholesterol, elevated triglycerides and hypertension, all risk
factors for atheroma formation
- Diabetes predisposes atherosclerosis development as high levels of glucose in blood
damages surface proteins on endothelial cells, proteins are glycated, endothelial dysfunction
causes development of atherosclerosis



Diagnosis of diabetes:

- Symptoms include increased drinking (polydipsia) and increased frequency of urination
(polyuria)
- Type 1 DM associated with weight loss (despite increased eating) and fatigue
- Type 2 DM associated with weight gain and sensory abnormalities (e.g. numbness,
tingling pain)
- Test for glycated haemoglobin (HbA1c) above 48mmol / mol (glucose stuck to
haemoglobin)
- Red blood cells last for ~120 days, so avoids fluctuations of blood [glucose]



Physiology of insulin: mechanism of release:

- Uptake of glucose in the pancreatic beta cells by glucose transporter GLUT2 in response to an
increase in blood glucose.
- Glucokinase enzyme has a high affinity for glucose and is only active when glucose levels are
high converting glucose to glucose-6-phosphate
- When glucose enters the beta cells via GLUT2, it is metabolized through the process of
glycolysis generating ATP.
- The increase in ATP levels leads to the closure/inhibition of ATP-sensitive potassium (KATP)
channels, which allows depolarization of the beta cell membrane.
- Depolarization of the beta cell membrane leads to the opening of voltage-gated calcium
channels inducing calcium entry into the beta cell.

, - The increase in intracellular calcium levels triggers the fusion of insulin-containing vesicles
with the cell membrane, which releases insulin into the bloodstream.
- Goes onto lower the heightened blood-glucose levels.

Furthermore..

- When GIP binds to GIP-R receptor on the surface of beta cells, it activates Gαs, a G protein
that stimulates the production of cyclic AMP (cAMP)
- Increase cAMP acts to enhance the calcium current in the VDCC allowing for greater calcium
entry and thus exocytosis of insulin

- Oral glucose administration causes more insulin release than equivalent i.v. administration
suggesting G.I. factors also regulate (enhances) insulin release – incretins
- Glucagon-like peptide (GLP1), produced from intestinal L cells; acts on GLP1 receptor on
pancreatic  cells stimulating release of insulin
- Gastric inhibitory peptide (GIP), from intestinal K cells; acts on GIP receptor on pancreatic 
cells stimulating release of insulin




 GLUT-2: Low affinity; high capacity; constitutively present at membrane

 GLUT-4 (also some GLUT-1): High affinity; low capacity; requires insulin presence –
particularly in liver, skeletal muscle, adipose tissue (expressed in key tissues for insulin
effects)



Insulin:

- Insulin promotes glucose uptake and storage
- Stimulates the uptake of glucose by muscle and adipose tissue, and also stimulates the liver
to store glucose as glycogen
- To lower blood glucose levels and ensures that glucose is available for use as energy by the
body.
- Inhibits gluconeogenesis – making glucose from amino acids
- Increases lipogeneses – building triglycerides using glucose

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller isabellahampson. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $7.23. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

77254 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$7.23
  • (0)
  Add to cart